Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $7.0000 (2.19%) ($7.0000 - $7.0000) on Tue. Sep. 12, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.13% (three month average) | RSI | 44 | Latest Price | $7.0000(2.19%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -0.1% a day on average for past five trading days. | Weekly Trend | BCRX declines -1.9% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Normal for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) UNG(88%) IVW(55%) USO(45%) XOP(40%) XLE(35%) | Factors Impacting BCRX price | BCRX will decline at least -1.565% in a week (0% probabilities). ARKK(-91%) TAN(-83%) IGOV(-47%) XLRE(-36%) GDX(-32%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.565% (StdDev 3.13%) | Hourly BBV | 0.6 () | Intraday Trend | 0% | | | |
|
Resistance Level | $7.09 | 5 Day Moving Average | $6.95(0.72%) | 10 Day Moving Average | $7.02(-0.28%) | 20 Day Moving Average | $7.09(-1.27%) | To recent high | -15.8% | To recent low | 4.5% | Market Cap | $1.235b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |